Loading Events

Debunking 5 Common Myths Around Peritoneal Dialysis

Debunking 5 Common Myths Around Peritoneal Dialysis

Recent policymaking and an increased awareness around patient-centric care are resulting in a renewed interest in home-dialysis as a treatment option for kidney failure. Peritoneal dialysis is a great option to facilitate the freedom of home renal replacement therapy. Despite the long-history of this treatment modality as a viable option for many patients, its use remains relatively low in comparison to in-center hemodialysis. This presentation reviews and counters common perceived barriers to utilizing peritoneal dialysis in various populations.


Fleming’s Prime Steakhouse

255 E Basse Rd Bldg E-Suite #200
San Antonio, Texas 78209 United States
+ Google Map
(210) 824-9463 View Venue Website

Featured Speaker

Molly Jansen

Molly Jansen, PhD

Nephrology Clinical & Scientific Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Dr Molly Jansen is a Nephrology Clinical & Scientific Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. covering South Texas and New Mexico. Molly earned her Doctor of Philosophy degree in Biomedical Science from Wake Forest School of Medicine located in Winston-Salem, NC. While in graduate school, Molly worked as a Business Development Intern at Wake Forest Innovations, fostering the collaborative innovation between industry and the faculty and staff of Wake Forest Baptist Medical Center. After graduate school, Molly did a brief Medical Writing Fellowship with Impact Pharmaceutical Services. Prior to joining Otsuka, Molly worked at Reata Pharmaceuticals, Inc. where she helped to oversee the conduct of clinical trials across a variety of therapeutic areas including nephrology, neurology, and pulmonary, which is where she developed her passion for rare disease.

*Dr Jansen is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).